5 months ago
PFE
AnalystsAlexandria HammondAlexandria Hammond's Stock Forecasts
AnalystsAlexandria Hammond
Sectors:
Industries:
Analyst Ranking
Bottom 22%
#3850 out of 4861 analysts
Average Return
-5.22%
Win Rate
60%6 out of 10
Risk vs Reward
Poor
Good
Alexandria Hammond's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Moderna IncMRNA | +32.93% | $36.85 | $24.72 | 2024-11-15 - 2025-04-17 | Sell |
Gilead Sciences IncGILD | +18.26% | $88.40 | $104.54 | 2024-11-15 - 2025-04-17 | Buy |
Eli Lilly & CoLLY | +12.56% | $746.20 | $839.96 | 2024-11-15 - 2025-04-17 | Buy |
Pfizer IncPFE | +10.73% | $24.80 | $22.14 | 2024-11-15 - 2025-04-17 | Sell |
Abbvie IncABBV | +4.85% | $164.99 | $172.99 | 2024-11-15 - 2025-04-17 | Buy |
Alexandria Hammond Analyst Color
Get additional color on Alexandria Hammond's coverage of popular stocks
5 months ago
LLY
Alexandria Hammond's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Akero Therapeutics IncAKRO | 2 | Strong Buy | $63.00 | +67.42% | Upgrades | 3 months ago |
Regeneron Pharmaceuticals IncREGN | 1 | Buy | $1,150.00 | +104.20% | Initiates Coverage On | 5 months ago |
Pfizer IncPFE | 1 | Sell | $25.00 | +12.92% | Initiates Coverage On | 5 months ago |
Moderna IncMRNA | 1 | Sell | $40.00 | +61.85% | Initiates Coverage On | 5 months ago |
Eli Lilly & CoLLY | 1 | Buy | $1,000.00 | +19.05% | Initiates Coverage On | 5 months ago |
Johnson & JohnsonJNJ | 1 | Buy | $190.00 | +20.66% | Initiates Coverage On | 5 months ago |
Gilead Sciences IncGILD | 1 | Buy | $110.00 | +5.22% | Initiates Coverage On | 5 months ago |
Abbvie IncABBV | 1 | Buy | $205.00 | +18.50% | Initiates Coverage On | 5 months ago |
Madrigal Pharmaceuticals IncMDGL | 1 | Sell | $150.00 | -50.28% | Initiates Coverage On | a year ago |
89bio IncETNB | 1 | Strong Buy | $30.00 | +395.05% | Assumes | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.